Flat for Johnson & Johnson stock — buyers dominate, but short-term pullbacks possible

Traders Union
All News
Financial News
Johnson & Johnson rises 0.09% today

Highlights

Johnson & Johnson declared a $1.30 quarterly dividend for Q4 2025, raising its indicated annual dividend to $5.20 per share and marking its 63rd consecutive year of increases.
Recent filings show West Oak Capital LLC and Cullen Capital Management LLC reduced their Johnson & Johnson holdings, with West Oak Capital LLC making a significant reduction.
Johnson & Johnson will release its next earnings report on January 21, 2026, providing an upcoming catalyst for investors.

Dividend streak boosts sentiment as major holders trim stakes

Johnson & Johnson has declared a $1.30 quarterly dividend for Q4 2025, paid on December 9, 2025, reflecting the company's 63rd consecutive year of dividend increases and setting the indicated annual dividend at $5.20 per share. Recent corporate filings reveal that West Oak Capital LLC and Cullen Capital Management LLC reduced their positions in the stock, with West Oak Capital LLC making a significant reduction. The company is also preparing for its next earnings report scheduled for January 21, 2026.

Dynamic support holds amid mixed signals and overbought warnings

The Kijun level from Ichimoku on D1 ($200.16) is acting as dynamic support, while resistance is likely near the recent highs or the MA-5 ($210.33) region. Momentum indicators on the daily chart are mixed: both MACD and ADX indicate continued bullish momentum, though Stoch RSI and CCI show overbought conditions. BBP further confirms buyer dominance intraday, and the awesome oscillator also aligns with the upward trend, signaling potential but overbought territory warns of possible short-term pullbacks amid the ascent.

High upside probability as consolidation signals limited downside

For the coming week, JNJ is expected to trade between $208.50 and $213.50, consistent with a typical volatility band relative to current levels for a blue-chip stock. The probability of an upward move remains very high (above 80%), supported by ongoing bullish signals from weekly MACD, ADX, RSI, and major moving averages. The baseline scenario sees JNJ consolidating within this range, with a breakout above $213.50 opening the path for further gains, while a move below $208.50 could signal the start of a corrective phase.

Viktoras Karapetjanc, analyst at Traders Union, sees strong bullish fundamentals underpinning Johnson & Johnson’s uptrend. The expert highlights impressive dividend growth, resilience in the face of institutional outflows, and persistent upward momentum across key technical averages. Karapetjanc believes core investor confidence remains high despite mixed signals from some short-term indicators. "Pullbacks may occur, but JNJ’s robust macro and dividend story put the odds squarely in favor of further gains this quarter."

Previously it was reported that Johnson & Johnson is exhibiting a strong bullish trend, trading well above its major moving averages, with buy signals from MACD and ADX confirming underlying strength, while resilient financials and consistent dividend growth reinforce the positive outlook. However, several overbought indicators, including elevated RSI and CCI, highlight the risk of a near-term pullback or sideways movement as momentum begins to cool, with key support identified near $209 and resistance around $217.

Source of Data: JNJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.